EUVIMEDEUVIMED entdecken
Crossref

Stereotactic Radiosurgery and Radiotherapy for Vestibular Schwannoma in NF2 ‐Related Schwannomatosis

Manu Shrivastava iD, Beatrice Emmanouil, Rajeev Mathew, Dorothy Halliday, Allyson Parry, Jane Halliday, Samuel Mackeith

The Laryngoscope · 2024-05 · 134 (5) · 2364-2371

DOI: 10.1002/lary.31180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 20.11.2023. Verfasst von Manu Shrivastava und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ear, Nose and Throat Surgery, Oxford University Hospitals, Oxford, UK. Hauptthemen laut MEDLINE: Neurilemmoma, Neurofibromatoses, Neuroma, Acoustic, Radiosurgery. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To determine the long‐term control rates and hearing outcomes for growing vestibular schwannoma in NF2 ‐related schwannomatosis (NF2) treated with stereotactic radiosurgery (SRS) and fractionated radiotherapy (FRT).

Methods

Retrospective review of all patients treated with SRS/FRT between 1986 and2021 from a tertiary NF2 unit. Overall tumor control was defined as: (1) growth control (growth failure was defined as growth in any dimension of 3 millimetres or more from baseline post‐SRS/FRT), and (2) treatment control (no need for further intervention). Loss of serviceable hearing was defined as a drop in speech discrimination score below 50% after SRS/FRT.

Results

There were 81 cases, with a mean duration of follow‐up of 125 months. Overall control rate was 72% (58/81), with 80% (65/81) growth control and 74% (60/81) treatment control. There was a 5‐year actuarial survival of 77% and 10‐year survival of 71%. Forty‐three percent (30/69) of cases did not have serviceable hearing at baseline. Of those remaining, 49% (19/39) preserved serviceable hearing during follow‐up at a mean of 106 months. Actuarial survival for preservation of serviceable hearing at 5 and 10 years was 69% and 53%. There were poorer outcomes with increasing genetic severity, and with baseline tumor size >3 cm. No cases of SRS/FRT‐related malignancy were identified at a mean follow‐up of 10 years.

Conclusion

Stereotactic radiosurgery/fractionated radiotherapy are an effective option to treat growing vestibular schwannoma in patients with NF2 with the potential for hearing preservation in a proportion of patients. Level of Evidence 4—Case Series Laryngoscope , 134:2364–2371, 2024

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeurilemmomaNeurofibromatosesNeuroma, AcousticRadiosurgerySkin NeoplasmsHumansFollow-Up StudiesRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

NF2stereotactic radiosurgeryvestibular schwannoma

Autor:innen und Institutionen

  • Department of Ear, Nose and Throat Surgery, Oxford University Hospitals, Oxford, UK.
  • NHS England, Wellington House, London, UK.
  • Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Department of Genetics, Oxford University Hospitals, Oxford, UK.
  • Department of Neurology, Oxford University Hospitals, Oxford, UK.
  • Department of Neurosurgery, Oxford University Hospitals, Oxford, UK.

ORCID-Profile: Manu Shrivastava

Zitieren

APA

Shrivastava, M., Emmanouil, B., Mathew, R., Halliday, D., Parry, A., Halliday, J., & Mackeith, S. (2024). Stereotactic Radiosurgery and Radiotherapy for Vestibular Schwannoma in NF2 ‐Related Schwannomatosis. The Laryngoscope, 134(5), 2364-2371. https://doi.org/10.1002/lary.31180

Vancouver

Shrivastava M, Emmanouil B, Mathew R, Halliday D, Parry A, Halliday J, et al. Stereotactic Radiosurgery and Radiotherapy for Vestibular Schwannoma in NF2 ‐Related Schwannomatosis. The Laryngoscope. 2024;134(5):2364-2371. doi:10.1002/lary.31180

BibTeX
@article{Shrivastava2024,
  author = {Shrivastava, Manu and Emmanouil, Beatrice and Mathew, Rajeev and Halliday, Dorothy and Parry, Allyson and Halliday, Jane and Mackeith, Samuel},
  title = {Stereotactic Radiosurgery and Radiotherapy for Vestibular Schwannoma in NF2 ‐Related Schwannomatosis},
  journal = {The Laryngoscope},
  year = {2024},
  volume = {134},
  number = {5},
  pages = {2364--2371},
  doi = {10.1002/lary.31180}
}
Kostenlos starten →